Currently Viewing
Keeping Treatment Practices Apace with Recent Scientific Breakthroughs: A Great Challenge to Face
December 14, 2016 – Mike Hennessy, Sr.
Managing Immunotherapy Side Effects in Melanoma: Quick Intervention Is Key
December 13, 2016 – Allie Casey
In Watching for the Side Effects of Immunotherapy, You are Your Own First Line of Defense
December 13, 2016 – Debu Tripathy, MD
Partnering Up to Identify Melanoma
December 12, 2016 – Katie Kosko
A Rare Breed: Inherited Melanoma
December 09, 2016 – Leah K. Lawrence
A Ray of Truth: Protecting Skin from Melanoma in Cold Climates
December 09, 2016 – Katie Kosko
Working at the Speed of Light in Melanoma Advancements
December 08, 2016 – Christin Melton, ELST
Keeping Treatment Practices Apace with Recent Scientific Breakthroughs: A Great Challenge to Face
December 14, 2016 – Mike Hennessy, Sr.
Covering All the Bases: FDA Must Focus on Cancer Prevention
December 15, 2016 – Timothy Turnham, Ph.D.
Managing Immunotherapy Side Effects in Melanoma: Quick Intervention Is Key
December 13, 2016 – Allie Casey
In Watching for the Side Effects of Immunotherapy, You are Your Own First Line of Defense
December 13, 2016 – Debu Tripathy, MD
Partnering Up to Identify Melanoma
December 12, 2016 – Katie Kosko
A Rare Breed: Inherited Melanoma
December 09, 2016 – Leah K. Lawrence
A Ray of Truth: Protecting Skin from Melanoma in Cold Climates
December 09, 2016 – Katie Kosko
Working at the Speed of Light in Melanoma Advancements
December 08, 2016 – Christin Melton, ELST

Keeping Treatment Practices Apace with Recent Scientific Breakthroughs: A Great Challenge to Face

BY Mike Hennessy, Sr.
PUBLISHED December 14, 2016
OVER THE PAST FIVE YEARS, the advancements in treating advanced melanoma have been staggering. Eight new drugs have been approved in that time period, including four immunotherapies and four targeted drugs.

As the cancer with perhaps the most mutations, melanoma is eminently treatable with both these types of drugs, and that has made it an excellent testing ground — and success story — when it comes to scientific innovation. In clinical trials, even more drugs are being tested today as treatments for melanoma.

But even before additional drugs reach the market, a challenge — the best kind possible — faces scientists and doctors. Every day, as they treat melanoma patients, they must decide: How do we best use and sequence this host of new drugs in the clinic? All the answers are not in yet, but experts in the field are using their experience to provide guidance. That’s the kind of wisdom that was passed along in a panel discussion hosted this summer by OncLive, a website that is a sister to CURE® magazine and curetoday.com.

In this special issue of CURE®, we present you with coverage of that talk, which outlines current questions in the treatment of advanced melanoma, along with a host of expert recommendations. This information is not just for doctors, but should also be very helpful to patients, who can consider the stage and location of their melanoma and ask informed questions of their health care teams: What mutations are expressed by my melanoma? Should I be treated with targeted drugs or immunotherapy? Should I get immunotherapy after surgery? Should I apply for inclusion in a clinical trial?

Elsewhere in this issue, we remind you that the need for melanoma prevention measures does not end in the winter, when, in many parts of the nation, the heat of the sun is at bay. We discuss a variety of strategies for keeping yourself safe from the sun’s ultraviolet rays.

In a third feature article, we look at the very rare condition of inherited melanoma. While this condition is not treated differently than other melanomas, we discuss the potential merits of knowing about a family history of the disease, and about any mutations that could predispose someone to additional types of cancer.

We round out this issue with articles on the side effects of novel melanoma treatments; some legislative efforts aimed at helping patients; a look at a measure that can increase the efficacy of at-home skin checks; and a report on whether the ultraviolet lamps used in gel manicures increase melanoma risk.

We hope this special issue of CURE® gives you a well-rounded understanding of the issues associated with melanoma, from prevention to treatment to reducing the risk of recurrence. As always, thank you for reading.

MIKE HENNESSY, SR
Chairman and CEO
Be the first to discuss this article on CURE's forum. >>
Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.

Related Articles

1
×

Sign In

Not a member? Sign up now!
×

Sign Up

Are you a member? Please Log In